Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Clinical trial NCT05835778 · COMPLETED

Trial details

NCT number: NCT05835778
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Biliary Tract Cancer

Start date: 2023-06-06
Primary completion: 2025-11-21
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.